83 related articles for article (PubMed ID: 32100923)
41. FNDC3B and BPGM Are Involved in Human Papillomavirus-Mediated Carcinogenesis of Cervical Cancer.
Zhang L; Yu H; Deng T; Ling L; Wen J; Lv M; Ou R; Wang Q; Xu Y
Front Oncol; 2021; 11():783868. PubMed ID: 34976823
[TBL] [Abstract][Full Text] [Related]
42. Relationship between plasma glucose levels and malignant uterine cervical neoplasias.
Nomelini RS; Neto AS; Capuci KA; Murta BM; Murta EF
Clin Med Insights Oncol; 2011; 5():77-82. PubMed ID: 21603242
[TBL] [Abstract][Full Text] [Related]
43. Correlation between vaginal flora and cervical immune function of human papilloma virus-infected patients with cervical cancer.
Wang Q; Qin W; Gao W; Zhao K; Pan X; Jiang X; Zhao J
Afr Health Sci; 2023 Jun; 23(2):179-185. PubMed ID: 38223622
[TBL] [Abstract][Full Text] [Related]
44. An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review).
Karaviti E; Kontogiannis A; Anastopoulos A; Kotteas E; Gomatou G
Mol Clin Oncol; 2023 Aug; 19(2):61. PubMed ID: 37424625
[TBL] [Abstract][Full Text] [Related]
45. The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review.
Voidăzan ST; Dianzani C; Husariu MA; Geréd B; Turdean SG; Uzun CC; Kovacs Z; Rozsnyai FF; Neagu N
Biology (Basel); 2022 Jun; 11(7):. PubMed ID: 36101337
[TBL] [Abstract][Full Text] [Related]
46. Fluorescence in situ hybridization testing for the diagnosis of high-grade cervical abnormalities: a systematic review.
Earley A; Lamont JL; Dahabreh IJ; Cowan J; Feldman S; Uhlig K
J Low Genit Tract Dis; 2014 Jul; 18(3):218-27. PubMed ID: 24477173
[TBL] [Abstract][Full Text] [Related]
47. Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical Cancer Eradication?
Cascardi E; Cazzato G; Daniele A; Silvestris E; Cormio G; Di Vagno G; Malvasi A; Loizzi V; Scacco S; Pinto V; Cicinelli E; Maiorano E; Ingravallo G; Resta L; Minoia C; Dellino M
Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 35892970
[TBL] [Abstract][Full Text] [Related]
48. Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer.
He H; Pan Q; Pan J; Chen Y; Cao L
J Clin Lab Anal; 2020 Jul; 34(7):e23257. PubMed ID: 32100923
[TBL] [Abstract][Full Text] [Related]
49. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
50. [Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen].
Li YB; Wulan N; Liu ZH; Li J; Wang C; Zhou YQ; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):946-50. PubMed ID: 20193234
[TBL] [Abstract][Full Text] [Related]
51. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
[TBL] [Abstract][Full Text] [Related]
53. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
[TBL] [Abstract][Full Text] [Related]
54. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
Zhu Y; Han Y; Tian T; Su P; Jin G; Chen J; Cao Y
Pathol Res Pract; 2018 Mar; 214(3):374-379. PubMed ID: 29487007
[TBL] [Abstract][Full Text] [Related]
55. Effect of
Ashtiani M; Nabatchian F; Galavi HR; Saravani R; Farajian-Mashhadi F; Salimi S
Biomed Rep; 2017 Sep; 7(3):251-256. PubMed ID: 28811896
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
